Premium
Downregulation of MicroRNA‐320d predicts poor overall survival and promotes the growth and invasive abilities in glioma
Author(s) -
Qin ChongZhen,
Lv QiaoLi,
Yang YanTao,
Zhang JingMin,
Zhang XiaoJian,
Zhou HongHao
Publication year - 2017
Publication title -
chemical biology and drug design
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 77
eISSN - 1747-0285
pISSN - 1747-0277
DOI - 10.1111/cbdd.12906
Subject(s) - glioma , cell cycle , u87 , cancer research , cell growth , microrna , apoptosis , biology , downregulation and upregulation , western blot , cell culture , cell , cell cycle checkpoint , transfection , gene , genetics , biochemistry
Previous studies have demonstrated that miRNAs play an important role in tumor development and progression. The role of miR‐320d has been studied in several cancers except for glioma. The aim of the study was to investigate the expression levels, biological function, and mechanism of miR‐320d in glioma. The expression levels of miR‐320d were detected in glioma tissues and cell lines (U87 and U251) by RT‐qPCR. Cell proliferation, colony formation, apoptosis, cell cycle, and transwell assays were performed in glioma cell lines transfected with miR‐320d mimics or controls to evaluate the effects of miR‐320d in vitro. The expression levels of invasive‐related proteins were determined by Western blot analysis. Results showed that the expression of miR‐320d was significantly decreased in glioma tissues and cell lines. Overexpression of miR‐320d could significantly suppress cell growth, migration and invasion, and induced cell apoptosis as well as cell cycle at G0/G1 arrest in U87 and U251 cell lines. Additionally, expression levels of MMP‐2, MMP‐9, N‐cadherin, and integrin‐β1 reduced, while E‐cadherin increased in miR‐320d mimic group. Overall, this study is the first to demonstrate that miR‐320d may serve as an independent prognostic factor, indicating that miR‐320d is a biomarker for prognosis and therapy in glioma.